tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LVTX Stock Latest News

LAVA Therapeutics Announces Acquisition by XOMA Corporation
Company AnnouncementsLAVA Therapeutics Announces Acquisition by XOMA Corporation
2d ago
8K
LVTX
Lava Therapeutics reports Q2 EPS (32c) vs. (31c) last year
PremiumThe Fly
Lava Therapeutics reports Q2 EPS (32c) vs. (31c) last year
3d ago
LVTX
Hold Rating on XOMA’s Acquisition of LAVA Therapeutics: Valuation and Risks Assessed
PremiumRatings
Hold Rating on XOMA’s Acquisition of LAVA Therapeutics: Valuation and Risks Assessed
11d ago
LVTX
Lava Therapeutics downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Lava Therapeutics downgraded to Hold from Buy at Jefferies
11d ago
LVTX
LAVA Therapeutics Agrees to Acquisition by XOMA
PremiumCompany Announcements
LAVA Therapeutics Agrees to Acquisition by XOMA
12d ago
8K
LVTX
Xoma to acquire Lava Therapeutics for $1.16-$1.24 per share in cash plus CVR
PremiumThe FlyXoma to acquire Lava Therapeutics for $1.16-$1.24 per share in cash plus CVR
12d ago
LVTX
XOMA
Lava Therapeutics’ LAVA-1207 Study Terminated: Implications for Investors
Premium
Company Announcements
Lava Therapeutics’ LAVA-1207 Study Terminated: Implications for Investors
15d ago
LVTX
LAVA Therapeutics Shareholders Approve Key Proposals in Meeting
Premium
Company Announcements
LAVA Therapeutics Shareholders Approve Key Proposals in Meeting
2M ago
8K
LVTX
Hold Rating for LAVA Therapeutics Amid Strategic Changes and Clinical Progress
PremiumRatings
Hold Rating for LAVA Therapeutics Amid Strategic Changes and Clinical Progress
3M ago
LVTX
Lava Therapeutics reports Q1 EPS (13c) vs (2c) last year
PremiumThe Fly
Lava Therapeutics reports Q1 EPS (13c) vs (2c) last year
3M ago
LVTX
Lava Therapeutics granted full waiver for RVO payment obligation
PremiumThe Fly
Lava Therapeutics granted full waiver for RVO payment obligation
4M ago
LVTX
Hold Rating for LAVA Therapeutics Amid Strategic Review and LAVA-1266 Progress
PremiumRatings
Hold Rating for LAVA Therapeutics Amid Strategic Review and LAVA-1266 Progress
5M ago
LVTX
Lava Therapeutics Reports 2024 Financial Results
PremiumCompany AnnouncementsLava Therapeutics Reports 2024 Financial Results
5M ago
LVTX
Lava Therapeutics reports Q4 EPS (14c) vs. (24c) last year
Premium
The Fly
Lava Therapeutics reports Q4 EPS (14c) vs. (24c) last year
5M ago
LVTX
Lava Therapeutics sees cash runway into 2027
Premium
The Fly
Lava Therapeutics sees cash runway into 2027
5M ago
LVTX
Lava Therapeutics expects $1M of expenses related to restructuring plan
PremiumThe Fly
Lava Therapeutics expects $1M of expenses related to restructuring plan
5M ago
LVTX
LVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
LVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
LVTX
Cautious Stance on LAVA Therapeutics Amid Strategic Review and Workforce Reduction
PremiumRatings
Cautious Stance on LAVA Therapeutics Amid Strategic Review and Workforce Reduction
6M ago
LVTX
Lava Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Lava Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
6M ago
LVTX
Lava Therapeutics implements restructuring plan, workforce reduction of 30%
PremiumThe FlyLava Therapeutics implements restructuring plan, workforce reduction of 30%
6M ago
LVTX
LAVA Therapeutics Announces Restructuring Plan for 2025
Premium
Company Announcements
LAVA Therapeutics Announces Restructuring Plan for 2025
6M ago
8K
LVTX
Lava Therapeutics announces evaluation of strategic options
Premium
The Fly
Lava Therapeutics announces evaluation of strategic options
6M ago
LVTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >